EE411 Cost-Utility of Nabiximols for the Management of Spasticity Due to Multiple Sclerosis in Switzerland

Autor: Schwander, B, Dykukha, I, Merinova, M, Akmaz, B
Zdroj: In Value in Health December 2022 25(12) Supplement:S136-S136
Databáze: ScienceDirect